Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can cause fatigue. Clinical trial data and NHS prescribing information both record tiredness as a recognised side effect of semaglutide, the active ingredient in Wegovy. For most people it is mild, tends to be most noticeable in the early weeks of treatment or after a dose increase, and settles as the body adjusts. It is a prescription-only medicine, so a qualified prescriber assesses your suitability before treatment begins — and questions about side effects are very much part of that conversation. This page covers what the evidence says, why it happens, when to seek medical help, and how to tell normal adjustment from something that warrants a call to a clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (the pivotal 68-week phase 3 study of semaglutide 2.4 mg published in the New England Journal of Medicine) recorded fatigue among the adverse effects observed in the semaglutide group. It appeared more often in patients on active treatment than in those on placebo, and was most common during dose escalation rather than at steady maintenance. The NHS medicines page for semaglutide lists tiredness explicitly under common side effects, placing it alongside the more widely discussed gastrointestinal symptoms: nausea, diarrhoea, constipation and indigestion. These effects share a likely mechanism, semaglutide slows gastric emptying and suppresses appetite markedly, and your body's caloric intake drops at a time when it is still adapting. The result, for some people, is a period of genuine tiredness. Framing it that way is not minimising it; it is explaining why it tends to be self-limiting. If you are wondering whether semaglutide can cause fatigue and what drives it, the pattern across the trial data suggests that for the majority of participants who experienced it, tiredness was transient rather than a feature of the whole treatment course. That said, everyone's response differs, and a minority do find it persists beyond the early adjustment window, which is precisely why ongoing clinical review matters.
Semaglutide is a GLP-1 receptor agonist. Among its effects, it substantially reduces appetite and slows gastric emptying, which means many people eat considerably less in the weeks after starting or after each dose increase. Reduced caloric intake, lower carbohydrate consumption in particular, and the body's recalibration of its energy systems can all contribute to tiredness. It is not the medicine itself acting as a sedative; it is a downstream consequence of the changes in how your body is fuelled. This also explains why fatigue on Wegovy tends to cluster around dose transitions rather than settling in as a constant companion. Some people find that spreading their protein intake across the day, keeping well hydrated, and maintaining gentle activity helps, though specific nutritional guidance belongs with a dietitian or your prescriber rather than a general-purpose article. One small practical point: some patients who inject on a Monday report that having the pen ready in the fridge door, rather than hunting for it, removes one small friction from the routine. Consistency matters when you are tracking how your body responds week by week. Our page on why semaglutide causes fatigue goes further into the physiology if you want a deeper explanation.
Most tiredness in the first weeks of Wegovy is part of normal adjustment. There are circumstances, though, where exhaustion is a signal that something else is happening and prompt medical review is necessary. Seek urgent help if severe tiredness arrives alongside intense or persistent abdominal pain, particularly pain that radiates toward the back. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the combination of fatigue, severe stomach pain and vomiting is a reason to stop the injection and get assessed that day, not to wait and see. Fatigue paired with yellowing of the skin or eyes, dark urine, or significant swelling could point to gallbladder or liver involvement and equally warrants same-day medical contact. Extreme tiredness alongside signs of dehydration (dizziness on standing, very little urine output, persistent vomiting) is another reason to call your GP or 111 rather than push through. If you are uncertain whether what you are experiencing is within the expected range, that is what aftercare support is for. You can also find a broader overview of Wegovy's side effect profile on our Wegovy side effects page. And if you have a suspected side effect you want to record formally, the MHRA's Yellow Card scheme is open to patients as well as healthcare professionals.
The most common pattern, consistent with what was seen in the STEP programme, is that fatigue eases within two to four weeks of a dose increase as the body adapts. By the time patients reach a stable maintenance dose, most find the tiredness has receded significantly or disappeared. If you are asking how long it takes for Wegovy side effects to go away, the answer for fatigue in particular depends on where you are in the titration schedule, and a small proportion find it lingers longer, making a conversation with their prescriber important. There may be adjustments to timing, pace of titration, or supportive measures that help. Our pages on how long fatigue lasts on Wegovy and whether Wegovy fatigue goes away cover the timeline evidence in more detail. What the evidence does not support is pushing through significant fatigue silently. Semaglutide is a prescription-only medicine precisely because individual response varies and ongoing clinical oversight makes a difference. A prescriber cannot tell how your first few weeks are going unless you say. At nume, our prescribers discuss suitability, side effects and your experience as part of every clinical review, it is not a one-off assessment and then silence. If you are thinking about starting treatment or want to understand more about what to expect, speak to our prescribers as part of a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.